348 related articles for article (PubMed ID: 9242521)
21. alpha-fetoprotein causes apoptosis in tumor cells via a pathway independent of CD95, TNFR1 and TNFR2 through activation of caspase-3-like proteases.
Dudich E; Semenkova L; Dudich I; Gorbatova E; Tochtamisheva N; Tatulov E; Nikolaeva M; Sukhikh G
Eur J Biochem; 1999 Dec; 266(3):750-61. PubMed ID: 10583368
[TBL] [Abstract][Full Text] [Related]
22. Camptothecin-induced apoptosis in p53-null human leukemia HL60 cells and their isolated nuclei: effects of the protease inhibitors Z-VAD-fmk and dichloroisocoumarin suggest an involvement of both caspases and serine proteases.
Shimizu T; Pommier Y
Leukemia; 1997 Aug; 11(8):1238-44. PubMed ID: 9264376
[TBL] [Abstract][Full Text] [Related]
23. Affinity labeling displays the stepwise activation of ICE-related proteases by Fas, staurosporine, and CrmA-sensitive caspase-8.
Takahashi A; Hirata H; Yonehara S; Imai Y; Lee KK; Moyer RW; Turner PC; Mesner PW; Okazaki T; Sawai H; Kishi S; Yamamoto K; Okuma M; Sasada M
Oncogene; 1997 Jun; 14(23):2741-52. PubMed ID: 9190889
[TBL] [Abstract][Full Text] [Related]
24. Drug resistance towards etoposide and cisplatin in human melanoma cells is associated with drug-dependent apoptosis deficiency.
Helmbach H; Kern MA; Rossmann E; Renz K; Kissel C; Gschwendt B; Schadendorf D
J Invest Dermatol; 2002 Jun; 118(6):923-32. PubMed ID: 12060385
[TBL] [Abstract][Full Text] [Related]
25. Anticancer drugs induce caspase-8/FLICE activation and apoptosis in the absence of CD95 receptor/ligand interaction.
Wesselborg S; Engels IH; Rossmann E; Los M; Schulze-Osthoff K
Blood; 1999 May; 93(9):3053-63. PubMed ID: 10216102
[TBL] [Abstract][Full Text] [Related]
26. Effector caspases are dispensable for the early nuclear morphological changes during chemical-induced apoptosis.
Johnson VL; Ko SC; Holmstrom TH; Eriksson JE; Chow SC
J Cell Sci; 2000 Sep; 113 ( Pt 17)():2941-53. PubMed ID: 10934034
[TBL] [Abstract][Full Text] [Related]
27. Sequential activation of three distinct ICE-like activities in Fas-ligated Jurkat cells.
Greidinger EL; Miller DK; Yamin TT; Casciola-Rosen L; Rosen A
FEBS Lett; 1996 Jul; 390(3):299-303. PubMed ID: 8706881
[TBL] [Abstract][Full Text] [Related]
28. The CD95/CD95 ligand system is not the major effector in anticancer drug-mediated apoptosis.
Tolomeo M; Dusonchet L; Meli M; Grimaudo S; D'Alessandro N; Papoff G; Ruberti G; Rausa L
Cell Death Differ; 1998 Sep; 5(9):735-42. PubMed ID: 10200532
[TBL] [Abstract][Full Text] [Related]
29. Drug-induced apoptosis in lung cnacer cells is not mediated by the Fas/FasL (CD95/APO1) signaling pathway.
Ferreira CG; Tolis C; Span SW; Peters GJ; van Lopik T; Kummer AJ; Pinedo HM; Giaccone G
Clin Cancer Res; 2000 Jan; 6(1):203-12. PubMed ID: 10656451
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of caspases inhibits the release of apoptotic bodies: Bcl-2 inhibits the initiation of formation of apoptotic bodies in chemotherapeutic agent-induced apoptosis.
Zhang J; Reedy MC; Hannun YA; Obeid LM
J Cell Biol; 1999 Apr; 145(1):99-108. PubMed ID: 10189371
[TBL] [Abstract][Full Text] [Related]
31. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.
Zhang XD; Wu JJ; Gillespie S; Borrow J; Hersey P
Clin Cancer Res; 2006 Feb; 12(4):1355-64. PubMed ID: 16489094
[TBL] [Abstract][Full Text] [Related]
32. Selective induction of apoptosis in Hep 3B cells by topoisomerase I inhibitors: evidence for a protease-dependent pathway that does not activate cysteine protease P32.
Adjei PN; Kaufmann SH; Leung WY; Mao F; Gores GJ
J Clin Invest; 1996 Dec; 98(11):2588-96. PubMed ID: 8958222
[TBL] [Abstract][Full Text] [Related]
33. Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas.
Faubion WA; Guicciardi ME; Miyoshi H; Bronk SF; Roberts PJ; Svingen PA; Kaufmann SH; Gores GJ
J Clin Invest; 1999 Jan; 103(1):137-45. PubMed ID: 9884343
[TBL] [Abstract][Full Text] [Related]
34. Ligation of CD40 potentiates Fas-mediated activation of the cysteine protease CPP32, cleavage of its death substrate PARP, and apoptosis in Ramos-Burkitt lymphoma B cells.
An S; Yap D; Knox KA
Cell Immunol; 1997 Nov; 181(2):139-52. PubMed ID: 9398401
[TBL] [Abstract][Full Text] [Related]
35. Ex vivo pediatric brain tumors express Fas (CD95) and FasL (CD95L) and are resistant to apoptosis induction.
Riffkin CD; Gray AZ; Hawkins CJ; Chow CW; Ashley DM
Neuro Oncol; 2001 Oct; 3(4):229-40. PubMed ID: 11584892
[TBL] [Abstract][Full Text] [Related]
36. Common regulation of apoptosis signaling induced by CD95 and the DNA-damaging stimuli etoposide and gamma-radiation downstream from caspase-8 activation.
Boesen-de Cock JG; Tepper AD; de Vries E; van Blitterswijk WJ; Borst J
J Biol Chem; 1999 May; 274(20):14255-61. PubMed ID: 10318846
[TBL] [Abstract][Full Text] [Related]
37. Activation of the Fas pathway independently of Fas ligand during apoptosis induced by camptothecin in p53 mutant human colon carcinoma cells.
Shao RG; Cao CX; Nieves-Neira W; Dimanche-Boitrel MT; Solary E; Pommier Y
Oncogene; 2001 Apr; 20(15):1852-9. PubMed ID: 11313933
[TBL] [Abstract][Full Text] [Related]
38. p21WAF1 prevents down-modulation of the apoptotic inhibitor protein c-IAP1 and inhibits leukemic apoptosis.
Steinman RA; Johnson DE
Mol Med; 2000 Sep; 6(9):736-49. PubMed ID: 11071269
[TBL] [Abstract][Full Text] [Related]
39. Progressive resistance to apoptosis in a cell lineage model of human proliferative breast disease.
Starcevic SL; Elferink C; Novak RF
J Natl Cancer Inst; 2001 May; 93(10):776-82. PubMed ID: 11353788
[TBL] [Abstract][Full Text] [Related]
40. Antileukemic drugs increase death receptor 5 levels and enhance Apo-2L-induced apoptosis of human acute leukemia cells.
Wen J; Ramadevi N; Nguyen D; Perkins C; Worthington E; Bhalla K
Blood; 2000 Dec; 96(12):3900-6. PubMed ID: 11090076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
